Is your child currently experiencing UC flare-ups? Local CD clinical trial is testing a potential new medication to see if it may reduce urgency to defecate, diarrhea, abdominal pain, malnutrition, and/or anemia associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the CD clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing moderate to severe CD flare-ups? Local CD trial is testing a potential new medication to see if it may reduce fever, kidney stones, rectal pain, chronic fatigue, and/or joint pain associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the CD trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for child to join a Crohn’s disease clinical research study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe CD (including associated symptoms such as fever, fever, constant need to poop, chronic fatigue and/or liver disease), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

We are looking for young people aged 2 to 17 years to join a Crohn’s disease clinical research to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or ulcerative colitis (UC) (including associated symptoms such as abdominal cramping, persistent diarrhea, diarrhea, frequent fevers and/or eye pain), consider one of our trials. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce recurrent diarrhea, fatigue, rectal pain, chronic fatigue, and/or joint pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local CD clinical trial is testing a potential new medication to see if it may reduce diarrhea, weight loss, constant need to poop, weight loss, and/or liver disease associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the CD clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children 2–17 years old to join a trial to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe UC (including associated symptoms such as diarrhea, diarrhea, bloody stool, weight loss and/or canker sores), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing Crohn’s disease flare-ups? Local Crohn’s disease clinical research is testing a potential new medication to see if it may reduce diarrhea with blood and pus, abdominal cramps, cramps, malnutrition, and/or liver disease associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the Crohn’s disease clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children at least 2 years of age but under 18 to join a Crohn’s disease medical research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or moderate to severe IBD (including associated symptoms such as cramping, weight loss, abdominal pain, chronic fatigue and/or joint pain), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease (CD) trial is testing a potential new medication to see if it may reduce swollen joints, fatigue, bloody stool, weight loss, and/or eye pain associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease (CD) trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.